Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
DNA Script is revolutionizing DNA synthesis with its cutting-edge Enzymatic DNA Synthesis (EDS) technology. The company develops and commercializes novel platforms, like the SYNTAX System, enabling scientists to print synthetic DNA and RNA on-demand in their own labs. This empowers researchers in genomics, synthetic biology, and personalized medicine by providing unprecedented speed, control, and autonomy over their oligo supply, accelerating innovation and discovery.
Serves as DNA Script's European headquarters, housing key research and development, manufacturing, corporate operations, and strategic initiatives for enzymatic DNA synthesis technology.
Features state-of-the-art laboratories and advanced R&D facilities dedicated to the development and production of next-generation DNA synthesis platforms.
A dynamic, innovative, and collaborative environment fostering scientific excellence. It attracts top talent in biotechnology, chemistry, software, and engineering, all focused on pioneering DNA synthesis solutions.
The Paris-area headquarters is pivotal for DNA Script's core R&D, European market engagement, and strategic collaborations within the continent's vibrant life sciences ecosystem. It's also the company's founding location.
DNA Script operates with a significant global footprint, anchored by its dual headquarters in Le Kremlin-Bicêtre (Paris area), France, and South San Francisco, California, USA. The company supports a worldwide customer base through direct sales, service operations, and distribution partnerships across North America, Europe, and the Asia-Pacific region, delivering its on-demand DNA synthesis solutions to researchers and organizations globally.
67 avenue de Fontainebleau
Le Kremlin-Bicêtre
Île-de-France
France
Address: DNA Script Inc., 200 Kimball Way, South San Francisco, CA 94080, USA
To expand DNA Script's market presence in North America, provide dedicated support to US-based customers, and leverage the talent pool and innovation network of the San Francisco Bay Area.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, DNA Script' leadership includes:
DNA Script has been backed by several prominent investors over the years, including:
DNA Script has bolstered its executive team and board leadership over the past year with a new Chairman appointment and key internal promotions to Vice President positions, reflecting its ongoing expansion and strategic initiatives. No high-profile executive departures have been publicly announced during this period.
Discover the tools DNA Script uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
DNA Script commonly uses the email format [first_initial][last]@dnascript.com (e.g., jdoe@dnascript.com). This is the most frequently observed pattern for company communications. While other formats might exist in isolated cases, this structure has the highest probability of success.
[first_initial][last]@dnascript.com
Format
jdoe@dnascript.com
Example
86%
Success rate
dnascript.com • March 7, 2024
DNA Script announced the promotions of Patrick Eimerman, Ph.D., to Vice President of Business Development, and Bruno Larida to Vice President of Operations & Supply Chain, strengthening its leadership team to support company growth and strategic objectives....more
GEN - Genetic Engineering & Biotechnology News • November 1, 2023
DNA Script expanded its offerings by launching new RNA synthesis kits for its SYNTAX Platform. These kits enable researchers to produce custom single-guide RNA (sgRNA) and other RNA oligos on-demand in their own labs, advancing research in genome editing and RNA therapeutics....more
dnascript.com • June 6, 2023
DNA Script announced the appointment of Don Kania, Ph.D., a highly regarded life sciences executive, as the new Chairman of its Board of Directors. This move aims to leverage his expertise to guide the company's strategic direction and continued global expansion....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including DNA Script, are just a search away.